Skip to content

Role of DRP1 - Mediated Mitochondrial Fission in mtDNA Release and STING Signaling Activation in Ventilator - Induced Lung Injury

Role of DRP1 - Mediated Mitochondrial Fission in mtDNA Release and STING Signaling Activation in Ventilator - Induced Lung Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109056
Enrollment
Unknown
Registered
2025-09-11
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventilator-induced lung injury

Interventions

Ventilator-induced lung injury (VILI) group:None
Non-ventilator-induced lung injury group:None

Sponsors

Guangxi Medical University Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Ventilator-induced lung injury (VILI) group: Inclusion criteria: 1) Aged >= 18 years and receiving invasive mechanical ventilation for >= 48 hours; 2) Meet the diagnostic criteria for VILI (satisfy at least 2 of the following): a) Chest imaging (CT/X-ray) shows newly developed or progressive diffuse exudative lesions in both lungs; b) PaO2/FiO2 decreases by >= 20% compared with that before mechanical ventilation and is = 30 cmH2O or driving pressure >= 15 cmH2O); 3) Signed informed consent form. (2) Non-ventilator-induced lung injury group: Received mechanical ventilation for >= 48 hours and had no clinical and imaging evidence of VILI (PaO2/FiO2 was stable, with no newly developed exudation or progressive diffuse exudative lesions in both lungs).

Exclusion criteria

Exclusion criteria: (1) Concurrent chronic lung disease (COPD, pulmonary fibrosis, etc.) or active pulmonary infection (pathogen positive/PCT >= 0.5 ng/mL); (2) Immune suppression state (HIV infection, long-term use of hormones/immune suppressants); (3) Receive immunomodulatory therapy (such as IL-6/TNF-a antagonists) within 7 days; (4) Hemodynamic instability (MAP 1.5, platelets < 50×10?/L).

Design outcomes

Primary

MeasureTime frame
mtDNA;Stimulator of interferon genes(STING); ABG(Arterial Blood Gas);

Secondary

MeasureTime frame
IL-6;TNF-a;NF-?B;Macrophage polarization;Mitochondrial membrane potential;ATP(adenosine 5'-triphosphate);mitochondrial superoxide;

Countries

China

Contacts

Public ContactXianlong Xie

Guangxi Medical University Cancer Hospital

xiexianlong@stu.gxmu.edu.cn+86 159 7748 1518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026